Authors


Chad Ellimoottil, MD, MS

Latest:

Chad Ellimoottil, MD, on how urologists should approach telehealth in changing policy environment

"I say with a lot of confidence, just continue using telehealth as you are," says Chad Ellimoottil, MD, MS.


Igor Sorokin, MD

Latest:

Quiz: Testicular trauma in 21-year-old

A 21-year-old male presented to the emergency department for evaluation of testicular pain and swelling 5 days after being struck in the groin.


Daniel J. Lee, MD

Latest:

Cost considerations in the management of bladder cancer

"We will review the evidence and identify potential areas of improvement that can help reduce costs associated with UCB management while improving outcomes," write Daniel J. Lee, MD, and Sam S. Chang, MD.


H. Ballentine Carter, MD

Latest:

ABU: Life-long learning will be relevant, less burdensome

"The ABU is committed to evolving a [life-long learning] program that diplomates find relevant and less burdensome. We will always welcome diplomates’ feedback regarding this evolving program," writes H. Ballentine Carter, MD.


Gopal H. Badlani, MD

Latest:

SoBPD: How many ways can you treat BPH or BPD?

"Sometimes, there is more than a single answer to a question; this certainly applies to patients with benign prostatic disease," writes Gopal H. Badlani, MD.


Brian Henderson

Latest:

Congressional retirements promise to make waves

"No matter the most accurate interpretation of the current spate of retirements, the volume of vacancies promises to alter the political calculus in Washington," writes the AACU's Brian Henderson.


Michael S. Leapman, MD

Latest:

Future Directions in Prostate Cancer Management: An Evolving Treatment Landscape

Closing out his discussion on prostate cancer, Michael S. Leapman, MD, MHS, highlights practical advice and shares hope for future improvements in the treatment landscape.


Landon W. Trost, MD

Latest:

An expert discusses patient counseling in wake of FDA’s labeling changes for testosterone

“It definitely makes it easier for providers [to counsel patients]," says Landon Trost, MD.


Sara Valente, MD

Latest:

Challenging cases in urology: A case of hydronephrosis, sepsis, and pain

A 61-year-old female complains of acute-onset right-sided flank and abdominal pain. She describes associated nausea, but denied urinary symptoms, hematuria, fever, or chills.


Brianne Goodwin, JD, RN

Latest:

IPP suit hinges on expert’s lack of credibility

"The expert testified that the standard of care after penile prosthesis surgery is to leave the implant in a semi-inflated state for 4 to 6 weeks, when in fact the standard is to keep the implant in a deflated state," writes Brianne Goodwin, JD, RN.


Nirmish Singla, MD

Latest:

Challenging case: Hematuria in man with a history of prostate Ca

A 63-year-old African-American male presents to the emergency department with sudden onset of painless gross hematuria for one day. He reports dark red urine with clots causing occasional dysuria, difficulty emptying, and light-headedness.


Reynaldo Gomez, MD

Latest:

Bulbomembranous urethroplasty: External sphincter-sparing approach

"This article describes the surgical steps in this new technique and our promising preliminary results," writes Reynaldo Gomez, MD.


Brandon Manley, MD

Latest:

A new castration-resistant prostate cancer entity?

Urology Times SUO internship program member Brandon Manley, MD, reports on an SUO presentation highlighting several interesting findings on advanced prostate cancer with variant histology.


Ryan Hutchinson, MD

Latest:

Prostate Ca focal therapy’s value awaits high-quality data

In the arena of focal therapy for prostate cancer, standardization of management will be a key component of quality data going forward, says Scott Eggener, MD.


William Parker, MD

Latest:

Trials explore immune checkpoint blockade in NMIBC

Peter C. Black, MD, discusses the current state of immune checkpoint inhibition for bladder cancer in this article from Urology Times SUO internship program member William Parker, MD.


Katie S. Murray, DO, MS

Latest:

Low-Grade, Intermediate-Risk NMIBC: The Hidden Lesion

Panelists discuss how UGN-102, a reverse thermal hydrogel formulation of mitomycin, offers an FDA-approved ablative treatment option for patients with intermediate-risk non-muscle invasive bladder cancer (NMIBC), demonstrating 80% complete response rates in the ENVISION trial (NCT05243550) and allowing for the de-escalation of surveillance and reduced surgical burden.


Stacy Loeb, MD, MSc

Latest:

Why is AS for prostate Ca not used more?

"As a urologic community, we should promote the use of AS for favorable-risk disease to reduce the downstream harms of screening while preserving the benefits of early detection for life-threatening cases," writes Stacy Loeb, MD, MSc.


Michael G. Santomauro, MD

Latest:

Robotic suprapubic simple prostatectomy: Step-by-step approach

In this video, Nicholas R. Rocco, MD, Michael G. Santomauro, MD, and colleagues, illustrate a safe and effective way to treat a large-volume prostate causing obstructive lower urinary tract symptoms.


Christopher B. Dechet, MD

Latest:

Robotic cystectomy: Ileal conduit

This video depicts a robot-assisted laparoscopic cystectomy with intracorporeal ileal conduit for patients with muscle-invasive bladder cancer.


Jonathan N. Warner, MD

Latest:

Robotic cystectomy: Y-shaped neobladder technique

This video demonstrates a technique for the intracorporeal creation of a robot-assisted Y-shaped neobladder after cystectomy.


Robert M. Turner, II, MD

Latest:

High-grade bladder Ca: New data improve risk stratification

“We need to identify those patients with high-grade T1 bladder cancer that are likely to recur or progress… and find additional options to prevent recurrence and progression in these patients,” said Joaquim Bellmunt, MD, PhD, in a presentation at the SUO annual meeting.


Amy M. Pearlman, MD

Latest:

Pearls & Perspectives: Bringing the Magic Back to Medicine, with David Canes, MD

Canes describes the challenges of modern urology practice, from the deluge of portal messages to the variability in how clinicians deliver pre- and post-visit instructions


Keith Loria

Latest:

Can remote patient monitoring enhance your practice?

“[The ability of] remote patient monitoring to provide targeted clinical information to physicians and elevate critical information for review and earlier intervention is enhancing patient communication and care delivery,” said Jim Brown, MD.


Joshua A. Broghammer, MD

Latest:

AUS placement: Updated perineal approach

Urologists demonstrate several techniques to help the occasional AUS implanter avoid complications.


Uwais B. Zaid, MD

Latest:

AUS placement: Key steps in the Duke technique

This video, from Andrew C. Paterson, MD, and Uwais B. Zaid, MD, describes a technique for the placement of the male bulbar artificial urinary sphincter.


Woodson W. Smelser, MD

Latest:

BCG-unresponsive NMIBC: Current evidence and options

Multiple investigational agents have been developed and are being studied.


Sean Elliott, MD, MS

Latest:

AUS placement: The 30-minute technique

Sean Elliott, MD, MS, presents a streamlined, 30-minute approach to AUS insertion.


Andrew C. Paterson, MD

Latest:

AUS placement: Key steps in the Duke technique

This video, from Andrew C. Paterson, MD, and Uwais B. Zaid, MD, describes a technique for the placement of the male bulbar artificial urinary sphincter.


Seth A. Cohen, MD

Latest:

Urologists, GYNs demonstrate slings’ safety

"An abstract authored by Löppenberg et al is an interesting analysis of information from a respected prospective database examining variations in the quality of care provided to patients undergoing sling placement by gynecologists and urologists," write Seth A. Cohen, MD, and Shlomo Raz, MD.


Faris Azzouni, MD

Latest:

Letter to the editor: Consider foreign urologists as solution to shortage

In this letter to the editor, Faris Azzouni, MD, makes his case for foreign urologists as a solution to the urologist shortage.

© 2025 MJH Life Sciences

All rights reserved.